The European Commission has delayed the obligation of pharmaceutical traceability with Datamatrix codes until the end of 2018 due to the delay of the publication of the delegated acts, which are necessary to detail the operation and implementation of the system in the different actors in the chain .
The new date? End of 2015; From that time, Member States have a period of three years to implement the traceability chain of drugs (2018)
The purpose of the standard is patient safety, how? Identifying drugs from production to dispensing, especially those who are part of drugs susceptible to counterfeiting (for atypical conditions, very specific treatments, etc.)
The datamatrix will include product ID, serial number, country code, lot number and expiration date.
For the full text of the standard, go to the website of the European Commission